Purple Biotech Ltd. American Depositary Shares (PPBT) is a publicly traded Healthcare sector company. As of May 21, 2026, PPBT trades at $2.81 with a market cap of $3.51M and a P/E ratio of 0.00. PPBT moved -11.11% today. Year to date, PPBT is -57.03%; over the trailing twelve months it is -87.63%. Its 52-week range spans $2.71 to $139.50. Analyst consensus is buy with an average price target of $30.00. Rallies surfaces PPBT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own PPBT include Citadel Advisors. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Purple Biotech Ltd. American Depositary Shares.
| Metric | Value |
|---|---|
| Price | $2.81 |
| Market Cap | $3.51M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $139.50 |
| 52-Week Low | $2.71 |
| Volume | 10.14K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover PPBT: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $30.00.